Published Scientific Evidence
Category: (Cardiac Amyloidosis)
Anumana’s ECG-AI® technology is supported by one of the most extensive evidence bases in cardiovascular AI. This library provides direct access to our peer-reviewed validation studies and broader body of clinical research.
August
30
2024
{post_date: F d, Y}
Wiley Online Library
Predictors of mortality by an artificial intelligence enhanced electrocardiogram model for cardiac amyloidosis
Aims: We aim to determine if our previously validated, diagnostic artificial intelligence (AI) electrocardiogram (ECG) model is prognostic for survival among patients with cardiac amyloidosis (CA). Methods: A total of…